Finance

Lists
500087:BOM
Cipla Ltd
1 303,30 INR
-0,13%
(-1,70) 1D
9 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 500087...
Open
1 308,05 INR
High
1 316,55 INR
Low
1 295,90 INR
Mkt. cap
1,05 ტრლ.
Avg. vol.
46,06 ათ.
Volume
23,94 ათ.
Dividend
1,00%
Quarterly dividend
3,25 INR
Ex-dividend date
5 ივნ. 2026
P/E ratio
31,25
52-wk high
1 672,20 INR
52-wk low
1 165,55 INR
EPS
41,70 INR
Shares outstanding
805,67 მლნ.
No. of employees
31 ათ.
Open
1 308,05 INR
High
1 316,55 INR
Low
1 295,90 INR
Mkt. cap
1,05 ტრლ.
Avg. vol.
46,06 ათ.
Volume
23,94 ათ.
Dividend
1,00%
Quarterly dividend
3,25 INR
Ex-dividend date
5 ივნ. 2026
P/E ratio
31,25
52-wk high
1 672,20 INR
52-wk low
1 165,55 INR
EPS
41,70 INR
Shares outstanding
805,67 მლნ.
No. of employees
31 ათ.
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
4 საათის წინ
(CVCO) Risk Channels and Responsive Allocation
Yahoo Finance
Yahoo Finance
·
11 საათის წინ
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
MyStateline
MyStateline
·
1 დღის წინ
Wall Street finishes its record-setting week with gains
Profile
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
About Cipla Ltd
CEOუმანგ ვოჰრა
Employees31,4 ათ.
Founded1935
Headquartersმუმბაი, მაჰარაშტრა, ინდოეთი
SectorPharmaceutical industry
Websitecipla.com
Last report
23 ივლ. 2026
Fiscal period
Q1 2027
9,76 INR / 10,42 INR
-6,36%miss
Revenue / Est. (INR)
70,77 მლრდ. / 71,42 მლრდ.
-0,91%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
74,47 მლრდ.
69,63 მლრდ.
65,80 მლრდ.
70,77 მლრდ.
Cost of goods sold
24,98 მლრდ.
26,32 მლრდ.
25,10 მლრდ.
26,67 მლრდ.
Cost of revenue
24,98 მლრდ.
26,32 მლრდ.
25,10 მლრდ.
26,67 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13,15 მლრდ.
13,25 მლრდ.
28,23 მლრდ.
14,97 მლრდ.
Operating expense
33,52 მლრდ.
33,54 მლრდ.
33,30 მლრდ.
35,22 მლრდ.
Total operating expenses
58,50 მლრდ.
59,86 მლრდ.
58,39 მლრდ.
61,89 მლრდ.
Operating income
15,98 მლრდ.
9,77 მლრდ.
7,41 მლრდ.
8,88 მლრდ.
Other non operating income
2,69 მლრდ.
2,06 მლრდ.
-5,35 მლრდ.
2,11 მლრდ.
EBT including unusual items
18,54 მლრდ.
8,93 მლრდ.
6,99 მლრდ.
10,80 მლრდ.
EBT excluding unusual items
18,54 მლრდ.
11,69 მლრდ.
4,51 მლრდ.
10,80 მლრდ.
Income tax expense
5,00 მლრდ.
2,19 მლრდ.
1,57 მლრდ.
2,95 მლრდ.
Effective tax rate
27,00%
24,48%
22,44%
27,29%
Other operating expenses
17,40 მლრდ.
17,51 მლრდ.
2,51 მლრდ.
17,20 მლრდ.
Net income
13,51 მლრდ.
6,76 მლრდ.
5,55 მლრდ.
7,89 მლრდ.
Net profit margin
18,14%
9,71%
8,43%
11,15%
Earnings per share
16,72
10,94
6,86
9,76
Interest and investment income
-
-
2,07 მლრდ.
-
Interest expense
-131,80 მლნ.
-140,30 მლნ.
-69,70 მლნ.
-170,30 მლნ.
Net interest expenses
-131,80 მლნ.
-140,30 მლნ.
2,00 მლრდ.
-170,30 მლნ.
Depreciation and amortization charges
2,97 მლრდ.
2,78 მლრდ.
2,56 მლრდ.
3,04 მლრდ.
EBITDA
18,73 მლრდ.
12,00 მლრდ.
9,82 მლრდ.
11,29 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები